Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Calcium deposition in necrotic myocardium refers to the pathologic accumulation of calcium salts within areas of dead or dying cardiac tissue, usually following injury or disruption of calcium-phosphorus homeostasis. This can occur as dystrophic calcification (in injured/necrotic myocardium with normal systemic calcium levels) or metastatic calcification (in normal myocardium with systemic disturbances, such as chronic renal failure or hyperparathyroidism)[1][2][4]. The process is most commonly seen in the setting of myocardial infarction, severe infection/sepsis, or metabolic disturbances, and may be visualized radiologically on cardiac imaging[1][2][3]. Calcified areas may contribute to mechanical dysfunction of the heart (stiffness, arrhythmias) and often persist after resolution of the acute insult, though partial or complete resolution may be possible in rare circumstances[3]. There is currently no definitive therapy for myocardial calcification except for cardiac transplantation in extreme cases[2][3][4].
Not applicable; no drugs target this "molecule/receptor" directly.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Calcium deposition in necrotic myocardium (None commonly used).